Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / PHARMACEUTICALS
-
Total 13F shares
-
1,282,854
-
Share change
-
-4,479
-
Total reported value
-
$80,042,370
-
Price per share
-
$62.35
-
Number of holders
-
86
-
Value change
-
-$524,720
-
Number of buys
-
26
-
Number of sells
-
40
Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2018
As of 31 Dec 2018,
INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,282,854 shares.
The largest 10 holders included
MORGAN STANLEY, Peak Asset Management, LLC, LPL Financial LLC, BANK OF AMERICA CORP /DE/, MADISON INVESTMENT HOLDINGS INC, BAROMETER CAPITAL MANAGEMENT INC., COMMONWEALTH EQUITY SERVICES, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CIBC Private Wealth Group, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.